http://www.bing.com/news/search?q=bio+drug&form=QBNR&format=rssSearch resultshttp://www.bing.com/rsslogo.gifhttp://www.bing.com/news/search?q=bio+drug&form=QBNR&format=rssCopyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a2c1a3d0dd44149b3b155053213ab83&url=https%3a%2f%2fwww.msn.com%2fen-us%2fmoney%2fother%2fj-j-to-buy-cancer-drug-technology-developer-firefly-bio-for-1-billion%2far-AA256mWT&c=11786350830633862229&mkt=en-usJune 8 (Reuters) - Johnson & Johnson said on Monday it will acquire biotech Firefly Bio for $1 billion in cash, as it looks to expand its cancer drug pipeline. Firefly's Firelink platform uses ...Mon, 08 Jun 2026 05:30:03 GMTReuters on MSNhttp://www.bing.com/th?id=ONUT.uBNO5OVujpAD8UYa2ejMzg&pid=Newsw={0}&h={1}&c=14800514http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a2c1a3d0dd44149b3b155053213ab83&url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fjohnson-johnson-to-buy-firefly-bio-for-1-billion-to-boost-cancer-drugs%2far-AA25dk7H&c=12521863222409851719&mkt=en-usJohnson & Johnson will buy Firefly Bio for $1 billion, adding its Firelink platform to target KRAS-driven cancer tumors.Tue, 09 Jun 2026 09:57:41 GMTMSN on MSNhttp://www.bing.com/th?id=ONUT.Wce1IAe2S7CowDm5RVH1MQ&pid=Newsw={0}&h={1}&c=141280849http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a2c1a3d0dd44149b3b155053213ab83&url=https%3a%2f%2fwww.tmcnet.com%2fusubmit%2f2026%2f06%2f09%2f10396172.htm&c=16253669003025626141&mkt=en-usFDA cleared the Harmony-HHT Phase 1/2 study design, enabling Atavistik Bio to leverage existing clinical data with ATV-1601 and advance directly into a randomized study with indiv ...Tue, 09 Jun 2026 04:07:00 GMTTMCnethttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a2c1a3d0dd44149b3b155053213ab83&url=https%3a%2f%2ffinance.yahoo.com%2fsectors%2fhealthcare%2farticles%2fformation-bio-doses-first-participant-130000049.html&c=12800794018482103896&mkt=en-usFormation Bio, an AI-native pharma company, today announced dosing of the first participant in a Phase 1, first-in-human (FIH) clinical trial of BLKR201. The study, BLKR201-101-HV, is a single ...Tue, 09 Jun 2026 07:44:00 GMTYahoo Financehttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a2c1a3d0dd44149b3b155053213ab83&url=https%3a%2f%2fwww.earth.com%2fnews%2fscientists-uncover-the-barriers-keeping-blockbuster-drugs-expensive%2f&c=15874590539083486712&mkt=en-usA new study reveals why cheaper versions of blockbuster biologic drugs often face delays, keeping costs high for patients around the world.Wed, 10 Jun 2026 06:36:00 GMTEarth.comhttp://www.bing.com/th?id=ONUT.VFRTLBo43m5NpT9aYP_t0w&pid=Newsw={0}&h={1}&c=1425001665http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a2c1a3d0dd44149b3b155053213ab83&url=https%3a%2f%2fwww.biopharmadive.com%2fnews%2fjnj-firefly-acquisition-deal-cancer-degrader-antibody-conjugate%2f822223%2f&c=12105004559946996878&mkt=en-usThe buyout hands J&J a technology that merges elements of two popular drugmaking methods: protein degraders and antibody-drug conjugates.Mon, 08 Jun 2026 04:26:00 GMTBioPharma Divehttp://www.bing.com/th?id=ONUT.Dr0JOsXtxmyVlRkr7_CDhw&pid=Newsw={0}&h={1}&c=14653435http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a2c1a3d0dd44149b3b155053213ab83&url=https%3a%2f%2ffinance.yahoo.com%2fsectors%2fhealthcare%2farticles%2fcrossbridge-bio-enters-agreement-acquired-120000186.html&c=6036755910249039614&mkt=en-usCrossBridge Bio, Inc., a pre-clinical biotechnology company pioneering the development of next-generation dual-payload antibody-drug conjugates (ADCs) today announced a definitive agreement to be ...Tue, 14 Apr 2026 05:45:00 GMTYahoo Financehttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a2c1a3d0dd44149b3b155053213ab83&url=https%3a%2f%2fwww.nasdaq.com%2farticles%2ftevogen-bio-highlights-ai-advancements-drug-development-jp-morgan-healthcare-conference&c=6693953682223345731&mkt=en-usTevogen Bio Holdings Inc., a clinical-stage biotech firm specializing in immunotherapy, discussed its advancements in artificial intelligence (AI) during the J.P. Morgan Healthcare Conference. The ...Thu, 23 Jan 2025 16:59:00 GMTNasdaqhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a2c1a3d0dd44149b3b155053213ab83&url=https%3a%2f%2fmedcitynews.com%2f2024%2f03%2fbiotech-ipo-cancer-drug-resistance-gene-amplification-boundless-bio%2f&c=11210921004709511034&mkt=en-usTargeted therapies and immunotherapies offer new treatment options for more types of cancer, but these drugs are less helpful when tumors produce multiple copies of a gene. This gene amplification ...Thu, 28 Mar 2024 06:15:00 GMTMedCity Newshttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a2c1a3d0dd44149b3b155053213ab83&url=https%3a%2f%2fwww.alleywatch.com%2f2025%2f05%2finductive-bio-ai-drug-discovery-small-molecule-optimization-admet-collaboration-platform-josh-haimson%2f&c=4457364393854539429&mkt=en-usIn the complex and costly world of pharmaceutical development, the process of drug discovery remains one of the most significant bottlenecks, with scientists often describing compound optimization as ...Fri, 16 May 2025 06:28:00 GMTalleywatch.comhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a2c1a3d0dd44149b3b155053213ab83&url=https%3a%2f%2fwww.cnn.com%2f2025%2f10%2f29%2fhealth%2ffda-drug-costs-biosimilars&c=8115950834315155290&mkt=en-usThe US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...Tue, 28 Oct 2025 16:59:00 GMTCNNhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a2c1a3d0dd44149b3b155053213ab83&url=https%3a%2f%2fwww.msn.com%2fen-us%2fmoney%2fcompanies%2fthe-space-race-is-coming-for-pharma-why-drug-development-is-heading-to-lower-earth-orbit%2far-AA25aQ3o&c=13617743567305061921&mkt=en-usCompanies see a commercial opportunity in creating new ways to administer drugs to patients – in space.Tue, 09 Jun 2026 02:42:00 GMTCNBC on MSNhttp://www.bing.com/th?id=ONUT.jHsYuKpec4PpZx8wgR3HVA&pid=Newsw={0}&h={1}&c=1419201080